Home / Chroniques / Vaccine passport: why so much doubt?
vaccine passport
π Health and biotech π Society

Vaccine passport : why so much doubt ?

Etienne Minvielle
Etienne Minvielle
Director of the Centre de Recherche en Gestion at Ecole Polytechnique (IP Paris)

Accor­ding to a sur­vey by the Eco­no­mic, Social and Envi­ron­men­tal Coun­cil 1, 67% of French people are “high­ly unfa­vou­rable” to the adop­tion of a “vac­cine pas­sport”. How do you explain this opposition ?

Étienne Min­vielle. The pas­sport offers a way to reo­pen places that are cur­rent­ly clo­sed and to start tra­vel­ling again. But many people see it as a form of infrin­ge­ment of indi­vi­dual free­doms and a poten­tial source of inequa­li­ty. The pas­sport is sup­po­sed to be an incen­tive for vac­ci­na­tion, yet access to vac­cines is still pro­ble­ma­tic. So, to gene­ra­lise a vac­cine pas­sport now would be giving free­doms to those who lucky few who have been able to bene­fit from it so far. 

Hence, this would create inequa­li­ties on both natio­nal and inter­na­tio­nal levels, like­ly to fuel bit­ter­ness of non-vac­ci­na­ted indi­vi­duals and sus­pi­cions of entit­le­ment. The cri­sis is put­ting social cohe­sion to the test, and the reluc­tance to put this pas­sport into cir­cu­la­tion is a tes­ti­mo­ny to this.

Who are those who oppose this passport ?

There is wides­pread fear of sur­veillance among most French people and the pas­sport, since it increases tra­cea­bi­li­ty, increases this fear. Many people also have doubts about the risks and effec­ti­ve­ness of vac­cines. We can see this clear­ly with the contro­ver­sy sur­roun­ding Astra­Ze­ne­ca’s doses : people are wor­ried about the lack of hind­sight and fear poten­tial side effects.

But it’s not just the cli­ni­cal sphere that is concer­ned. Many people unders­tand the medi­cal benefit/risk ratio but are still scep­ti­cal about the inten­tions of those who are pushing for vac­ci­na­tion. There is a social – almost iden­ti­ty-based – rejec­tion of poli­ti­cal and medi­cal elite. This scep­ti­cism can bor­der on conspi­ra­cy when citi­zens come to ima­gine col­lu­sion bet­ween elites and phar­ma­ceu­ti­cal labo­ra­to­ries. We are the­re­fore seeing the emer­gence of a form of resis­tance, based on the rejec­tion of the dis­course of the elite, of which the first and fore­most is the government.

There is wides­pread fear of sur­veillance among most French people and the pas­sport, since it increases tra­cea­bi­li­ty, increases this fear.

How can those people be convin­ced of the effec­ti­ve­ness of vaccines ?

For people who have doubts about the cli­ni­cal effec­ti­ve­ness of vac­cines, medi­cal staff sim­ply need to explain the cli­ni­cal results, which prove that vac­cines are not dan­ge­rous. In the case of Astra­Ze­ne­ca, for example, no link bet­ween the vac­cine and throm­bo­sis has been demonstrated.

For those whose doubts are based on socio-iden­ti­ty cri­te­ria, the mis­take is to believe that words by doc­tors and autho­ri­ty figures are enough 2. The vac­ci­na­tion of elites can even send a nega­tive signal : the fact that Jean Cas­tex was vac­ci­na­ted with a dose of Astra­Ze­ne­ca can be inter­pre­ted as proof of his links with the labo­ra­to­ries. The res­ponse is the­re­fore not be cli­ni­cal, rather it is social. 

We need to deve­lop a dif­ferent kind of com­mu­ni­ca­tion, based on influen­cers playing the role of “trus­ted third par­ties” [Pre­sident Macron pro­mi­sed famous you­tu­bers McFly and Car­li­to to take part in one of their videos if they made a music video on pre­ven­tive mea­sures that rea­ched 10 mil­lion views]. The vac­ci­na­tion of rap­per Boo­ba (sug­ges­ted in a post on his Ins­ta­gram account) is in this sense not enti­re­ly anec­do­tal, not least because he is fol­lo­wed and lis­te­ned to by a some of these conspi­ra­cy theo­rists. The mixed reac­tion of his fans on social net­works shows the limits of this method : people are not foo­led, and often per­ceive this com­mu­ni­ca­tion as an attempt at manipulation.

So, there is no miracle solu­tion for convin­cing people who doubt ?

It is extre­me­ly dif­fi­cult to convince people who do not want to be convin­ced. To take just one example, one stu­dy sho­wed that parents who were reluc­tant to vac­ci­nate their chil­dren became even more scep­ti­cal when they were pre­sen­ted with data that shat­te­red the myth of autism risk due to vac­cines 3. Although coun­te­rin­tui­tive, this posi­tion does not reflect a lack of intel­li­gence. It demons­trates that scien­ti­fic evi­dence is rejec­ted when it dis­turbs beliefs.  It is the­re­fore not the conclu­sion that counts, but who pro­duces it.

The trans­mis­sion of infor­ma­tion is not just a sender/receiver rela­tion­ship ! It requires taking into account the whole social context : people are not just cli­ni­cal cases. In can­cer patients, for example, the rate of non-adhe­rence to pres­crip­tions is close to 20% in dif­ferent cli­ni­cal condi­tions 4 5. This results in consi­de­rable loss of oppor­tu­ni­ty and is inex­pli­cable from a strict­ly cli­ni­cal point of view. In the work we are cur­rent­ly doing, this non-adhe­rence seems to be explai­ned by social phe­no­me­na : the rela­tion­ship to life, the level of iso­la­tion, las­si­tude or the dete­rio­ra­tion of the pro­fes­sio­nal situa­tion. This social dimen­sion must be taken into account to opti­mise care. The same approach must be adop­ted to unders­tand the reluc­tance of citi­zens to be vac­ci­na­ted and the health passport.

Interview by Juliette Parmentier and Clément Boulle
1In French : https://​par​ti​ci​pez​.lecese​.fr/​p​a​g​e​s​/​r​e​s​u​l​t​a​t​s​-​d​e​-​l​a​-​c​o​n​s​u​l​t​a​t​i​o​n​-​s​u​r​-​l​e​-​p​a​s​s​e​p​o​r​t​-​v​a​c​cinal
2Rosen­baum, L. (2017). Resis­ting the sup­pres­sion of science. New England Jour­nal of Medi­cine, 376(17), 1607–1609.
3Nyhan B, Rei­fler J, Richey S, Freed GL. Effec­tive mes­sages in vac­cine pro­mo­tion : a ran­do­mi­zed trial. Pedia­trics 2014 ; 133(4): e835-e842.
4 http://​www​.blood​jour​nal​.org/​c​o​n​t​e​n​t​/​1​1​3​/​2​2​/​5​4​0​1​.​a​b​s​tract
5Pis­tilli, B., Paci, A., Fer­rei­ra, A., Di Meglio, A., Poin­si­gnon, V., Bar­det, A., … & Vaz-Luis, I. (2020). Serum detec­tion of nonadhe­rence to adju­vant tamoxi­fen and breast can­cer recur­rence risk. Jour­nal of Cli­ni­cal Onco­lo­gy, 38(24), 2762–2772

Contributors

Etienne Minvielle

Etienne Minvielle

Director of the Centre de Recherche en Gestion at Ecole Polytechnique (IP Paris)

A former intern at the Paris hospitals, a graduate of ESSEC and holder of a doctorate from the Ecole Polytechnique, Etienne Minvielle is also Director of Quality, Risk Management and Patient Relations at the Gustave Roussy Institute. He is director of the Centre de Recherche en Gestion (i3-CRG*) at Ecole Polytechnique (IP Paris). 
*I³-CRG: a joint research unit of CNRS, École Polytechnique - Institut Polytechnique de Paris, Télécom Paris, Mines ParisTech

Support accurate information rooted in the scientific method.

Donate